Tag: benefits

DRML Miner uses AI mining technology to seamlessly mine XRP, BTC, ETH, DOGE, and USDC — enjoy instant access, daily rewards, and zero hardware setup

U.S. dollar economy, tax incentives, and high rental demand are fueling international interest in Panama's booming property market

PhenQ 2025 OTC Fat Burner for Men: Medically accredited supplement gains national traction with expert-backed multi-action formula and user trust.

- Presentations highlight clinically meaningful reductions in BMI in patients with acquired hypothalamic obesity –

The Hottest Country by Far

Area 52 launches its new line of Disposable Weed Pens – backed by a 90-day 100% money back satisfaction guarantee.

Washington, D.C., July 12, 2025 (GLOBE NEWSWIRE) -- Following Ripple’s July 2 submission of a national banking license application to the U.S. Office of the Comptroller of the Currency (OCC), XRP holders worldwide are flocking to BJMINING, a leading cloud mining platform. Over the past week, the number of registered XRP users on BJMINING has surged by 300%. By converting idle XRP into mining power, users are unlocking a new passive income stream—earning up to $7,500 per day—while still retaining the benefits of traditional token holding. This trend highlights a deeper integration between the XRP ecosystem and next-generation financial tools, especially amid accelerating regulatory momentum.

NEW YORK, July 12, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

NEW YORK, July 12, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

EMERYVILLE, Calif., July 11, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that on July 8, 2025, the compensation committee of the Company’s board of directors granted one new non-executive employee 4,600 Restricted Stock Units (RSUs). The RSUs were granted pursuant to the Company’s 2025 Employment Inducement Award Plan, which was approved by the Company’s board of directors in February 2025 under Rule 5635(c)(4) of The Nasdaq Global Market for equity grants to induce new employees to enter into employment with the Company.